Wright Medical Augments Ortho Extremities Biz With BioMimetic Purchase

Firm expects to gain PMA approval in 2013 for BioMimetic’s Augment bone graft as a replacement for autologous bone graft in foot and ankle fusion procedures. Deal includes $190 million down, and up to $190 million more in milestone payments.

Wright Medical Group NV will gain access to BioMimetic Therapeutics Inc.’s Augment bone graft by acquiring the company for up to $380 million under a definitive agreement announced Nov. 19.

The deal includes $190 million down in cash and stock, plus up to $190 million more in milestone payments.

More from Deals

More from Business